Sutro Biopharma Inc
STRO
Market Cap$213.55M
Close$
$5.81
65.2% upside
Current Fair Value
65.2% upsideUndervalued by 65.2% based on the discounted cash flow analysis.
Share Statistics
| Market cap | $213.55 Million |
|---|---|
| Enterprise Value | $-128,431,487.00 |
| Dividend Yield | $0.0 (0.0%) |
| Earnings per Share | $-1.78 |
| Beta | 0.0 |
| Outstanding Shares | 62,441,963 |
| Avg 30 Day Volume | 1,237,225 |
Return
| Return on Equity | - |
|---|---|
| Return on Assets | - |
| Return on Invested Capital | - |
Valuation & Multiples
| P/E Ratio | -2.0 |
|---|---|
| PEG | 1.05 |
| Price to Sales | 1.76 |
| Price to Book Ratio | 1.76 |
| Enterprise Value to Revenue | -0.84 |
| Enterprise Value to EBIT | 1.44 |
| Enterprise Value to Net Income | 1 |
| Total Debt to Enterprise | -0.26 |
| Debt to Equity | 0.22 |
Revenue Sources
No data
ESG Score
No data
About Sutro Biopharma Inc
CEO: William Newell